Brandon Faubert to Lung Neoplasms
This is a "connection" page, showing publications Brandon Faubert has written about Lung Neoplasms.
Connection Strength
0.908
-
AIF: an acquired metabolic liability in lung cancer. Cell Res. 2019 08; 29(8):607-608.
Score: 0.291
-
Lactate Metabolism in Human Lung Tumors. Cell. 2017 Oct 05; 171(2):358-371.e9.
Score: 0.257
-
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020 12; 2(12):1401-1412.
Score: 0.080
-
Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer? Ann Thorac Surg. 2020 04; 109(4):1019-1025.
Score: 0.075
-
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer. Nat Commun. 2019 12 06; 10(1):5604.
Score: 0.075
-
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 2017 06 01; 546(7656):168-172.
Score: 0.063
-
Metabolic Heterogeneity in Human Lung Tumors. Cell. 2016 Feb 11; 164(4):681-94.
Score: 0.057
-
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011 May 15; 25(10):1041-51.
Score: 0.010